281 related articles for article (PubMed ID: 15901797)
1. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo.
Lorenzi PL; Landowski CP; Song X; Borysko KZ; Breitenbach JM; Kim JS; Hilfinger JM; Townsend LB; Drach JC; Amidon GL
J Pharmacol Exp Ther; 2005 Aug; 314(2):883-90. PubMed ID: 15901797
[TBL] [Abstract][Full Text] [Related]
2. N-methylpurine DNA glycosylase and 8-oxoguanine dna glycosylase metabolize the antiviral nucleoside 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Lorenzi PL; Landowski CP; Brancale A; Song X; Townsend LB; Drach JC; Amidon GL
Drug Metab Dispos; 2006 Jun; 34(6):1070-7. PubMed ID: 16565170
[TBL] [Abstract][Full Text] [Related]
3. Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporter.
Song X; Vig BS; Lorenzi PL; Drach JC; Townsend LB; Amidon GL
J Med Chem; 2005 Feb; 48(4):1274-7. PubMed ID: 15715497
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):802-10. PubMed ID: 9057867
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus.
Krosky PM; Borysko KZ; Nassiri MR; Devivar RV; Ptak RG; Davis MG; Biron KK; Townsend LB; Drach JC
Antimicrob Agents Chemother; 2002 Feb; 46(2):478-86. PubMed ID: 11796361
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
[TBL] [Abstract][Full Text] [Related]
7. Identification of acetylated, tetrahalogenated benzimidazole D-ribonucleosides with enhanced activity against human cytomegalovirus.
Hwang JS; Kregler O; Schilf R; Bannert N; Drach JC; Townsend LB; Bogner E
J Virol; 2007 Nov; 81(21):11604-11. PubMed ID: 17728228
[TBL] [Abstract][Full Text] [Related]
8. Interaction of intestinal nucleoside transporter hCNT2 with amino acid ester prodrugs of floxuridine and 2-bromo-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
Shin HC; Kim JS; Vig BS; Song X; Drach JC; Amidon GL
Biol Pharm Bull; 2006 Feb; 29(2):247-52. PubMed ID: 16462026
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).
Chan JH; Chamberlain SD; Biron KK; Davis MG; Harvey RJ; Selleseth DW; Dornsife RE; Dark EH; Frick LW; Townsend LB; Drach JC; Koszalka GW
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):101-23. PubMed ID: 10772705
[TBL] [Abstract][Full Text] [Related]
10. Dramatic effects of 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole riboside on the genome structure, packaging, and egress of guinea pig cytomegalovirus.
Nixon DE; McVoy MA
J Virol; 2004 Feb; 78(4):1623-35. PubMed ID: 14747528
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus.
Underwood MR; Ferris RG; Selleseth DW; Davis MG; Drach JC; Townsend LB; Biron KK; Boyd FL
Antimicrob Agents Chemother; 2004 May; 48(5):1647-51. PubMed ID: 15105116
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product.
Underwood MR; Harvey RJ; Stanat SC; Hemphill ML; Miller T; Drach JC; Townsend LB; Biron KK
J Virol; 1998 Jan; 72(1):717-25. PubMed ID: 9420278
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.
Evers DL; Komazin G; Ptak RG; Shin D; Emmer BT; Townsend LB; Drach JC
Antimicrob Agents Chemother; 2004 Oct; 48(10):3918-27. PubMed ID: 15388453
[TBL] [Abstract][Full Text] [Related]
14. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.
Biron KK; Harvey RJ; Chamberlain SC; Good SS; Smith AA; Davis MG; Talarico CL; Miller WH; Ferris R; Dornsife RE; Stanat SC; Drach JC; Townsend LB; Koszalka GW
Antimicrob Agents Chemother; 2002 Aug; 46(8):2365-72. PubMed ID: 12121906
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Porcari AR; Devivar RV; Kucera LS; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1252-62. PubMed ID: 9548815
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, physicochemical properties and antiviral activities of ester prodrugs of ganciclovir.
Patel K; Trivedi S; Luo S; Zhu X; Pal D; Kern ER; Mitra AK
Int J Pharm; 2005 Nov; 305(1-2):75-89. PubMed ID: 16242278
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral evaluation of polyhalogenated imidazole nucleosides: dimensional analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Chien TC; Saluja SS; Drach JC; Townsend LB
J Med Chem; 2004 Nov; 47(23):5743-52. PubMed ID: 15509173
[TBL] [Abstract][Full Text] [Related]
18. Studies designed to increase the stability and antiviral activity (HCMV) of the active benzimidazole nucleoside, TCRB.
Townsend LB; Gudmundsson KS; Daluge SM; Chen JJ; Zhu Z; Koszalka GW; Boyd L; Chamberlain SD; Freeman GA; Biron KK; Drach JC
Nucleosides Nucleotides; 1999; 18(4-5):509-19. PubMed ID: 10432642
[TBL] [Abstract][Full Text] [Related]
19. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiviral activity of certain 5'-modified analogs of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Gudmundsson KS; Drach JC; Wotring LL; Townsend LB
J Med Chem; 1997 Feb; 40(5):785-93. PubMed ID: 9057865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]